Search Results for "Myobloc"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Myobloc. Results 1 to 3 of 3 total matches.
See also: botulinum toxin

A New Botulinum Toxin (Xeomin) for Cervical Dystonia and Blepharospasm

   
The Medical Letter on Drugs and Therapeutics • Nov 15, 2010  (Issue 1351)
formulations of botulinum toxin type A (Botox; Dysport) and type B (Myobloc) are already marketed ...
The FDA has approved incobotulinumtoxinA (Xeomin – Merz) for treatment of cervical dystonia and blepharospasm in adults. It has been commercially available in Germany since 2005. Several formulations of botulinum toxin type A (Botox; Dysport) and type B (Myobloc) are already marketed for treatment of cervical dystonia. Botox is also approved for treatment of blepharospasm.
Med Lett Drugs Ther. 2010 Nov 15;52(1351):90-1 |  Show IntroductionHide Introduction

Botulinum Toxin for Cervical Dystonia

   
The Medical Letter on Drugs and Therapeutics • Jul 23, 2001  (Issue 1109)
type A (Botox − Allergan) and type B (Myobloc − Elan) are now approved by the FDA for treatment ...
Botulinum toxin type A (Botox - Allergan) and type B (Myobloc - Elan) are now approved by the FDA for treatment of cervical dystonia. Botulinum toxin type A has been approved since 1989 for treatment of strabismus and blepharospasm. It is also used cosmetically to reduce wrinkles on the face and neck.
Med Lett Drugs Ther. 2001 Jul 23;43(1109):63-4 |  Show IntroductionHide Introduction

Botulinum Toxin (Botox Cosmetic) for Frown Lines

   
The Medical Letter on Drugs and Therapeutics • May 27, 2002  (Issue 1131)
) and type B (Myobloc) are approved for treatment of cervical dystonia (Medical Letter 2001; 43:63), and type ...
Botulinum toxin type A (Botox Cosmetic - Allergan) has received formal approval from the FDA for treatment of glabellar ("frown") lines in adults not more than 65 years old, and is being heavily advertised. Even before this approval, cosmetic use of botulinum toxin to reduce wrinkles on the face and neck had become a popular alternative to cosmetic surgery (Medical Letter 1999; 41:63). Botulinum toxin type A (Botox) and type B (Myobloc) are approved for treatment of cervical dystonia (Medical Letter 2001; 43:53), and type A has been approved since 1989 for treatment of strabismus and...
Med Lett Drugs Ther. 2002 May 27;44(1131):47-8 |  Show IntroductionHide Introduction